REBEKA BROUILLARD: Open Payments
NPI 1063172724 · TRINITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 52 payments from 13 companies in 2025. Trend: 2023 $447 · 2024 $951 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $199 |
| PFIZER INC. | 8 | $140 |
| Exact Sciences Corporation | 9 | $137 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| Lilly USA, LLC | 4 | $81 |
| ABBVIE INC. | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Amgen Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: The Cologuard Plus Collection Kit, Ozempic, ELIQUIS, TRELEGY ELLIPTA, JARDIANCE, OTEZLA, MOUNJARO, QULIPTA.
Industry payments across FL — which companies pay providers there.
